TP53 and breast carcinoma: This gene is frequently somatically mutated in breast cancer [6,7] and TP53 germline mutations are associated with increased risk for developing diverse malignancies, including 25–30% of hereditary breast cancer cases associated with Li-Fraumeni syndrome [8].